Morningstar® Stock Report™

MorphoSys AG MPSYF

Gewinnmarge (% des Umsatzes)
20192020202120222023
Ertrag100,00%100,00%100,00%100,00%100,00%
Betriebskosten16,84%2,80%17,92%17,47%24,49%
Bruttogewinn83,16%97,20%82,08%82,53%75,51%
Vertriebsgemeinkosten82,69%48,56%85,86%32,42%38,84%
Forschung und Entwicklung151,11%43,16%125,39%107,02%119,03%
Umsatzrendite-150,65%5,48%-154,57%-79,32%-105,28%
Net Int, Inc and Other-299,10%12,34%-483,64%-73,02%-185,40%
EBIT Marge-148,45%6,86%-329,07%6,30%-80,13%
Ertragskraft
20192020202120222023
Steuersatz-4,89%-23,01%-42,64%60,58%-0,50%
Nettomarge-143,56%29,87%-286,43%-54,29%-79,63%
Gesamtkapitalrendite-19,909,08-24,41-6,10-8,58
Financial Leverage1,262,6710,4415,2341,31
Eigenkapitalsrendite-23,3319,27-118,79-75,10-183,80